Moderna plans to produce up to 3bn COVID-19 vaccine doses in 2022

Moderna said it would produce as many as 3 billion doses of its Covid-19 vaccine next year as it makes new investments to bolster output at several factories in the US and Europe. The biotech company said it would increase supply by 50 per cent at its Norwood, Massachusetts, plant, which makes much of the vaccine substance used in shots for the US market. The investments would also enable partner Lonza Group, which is making supply for foreign markets, to double its output at a factory in Switzerland that makes vaccine substance. Vaccine output at third factory in Spain operated by another partner, Laboratorios Farmaceuticos Rovi, would also more than double under the plan. The increased production from the company-owned and partner factories is expected to ramp up in late 2021 and early 2022, Moderna said.